SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 75 filers reported holding SAVARA INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $330,560 | +3.7% | 82,025 | +28.1% | 0.00% | – |
| Q1 2024 | $318,791 | +803.3% | 64,014 | +752.5% | 0.00% | – |
| Q4 2023 | $35,292 | +24.3% | 7,509 | 0.0% | 0.00% | – |
| Q3 2023 | $28,384 | +20.8% | 7,509 | +2.1% | 0.00% | – |
| Q2 2023 | $23,506 | +235.8% | 7,357 | +104.9% | 0.00% | – |
| Q1 2021 | $7,000 | +75.0% | 3,590 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 3,590 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -73.3% | 3,590 | -38.8% | 0.00% | – |
| Q2 2020 | $15,000 | +25.0% | 5,863 | +1.0% | 0.00% | – |
| Q1 2020 | $12,000 | -53.8% | 5,803 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | +116.7% | 5,803 | +30.7% | 0.00% | – |
| Q3 2019 | $12,000 | +9.1% | 4,440 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | -66.7% | 4,440 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | -2.9% | 4,440 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | -32.0% | 4,440 | 0.0% | 0.00% | – |
| Q3 2018 | $50,000 | +19.0% | 4,440 | +19.2% | 0.00% | – |
| Q2 2018 | $42,000 | – | 3,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,896,551 | $9,034,000 | 11.23% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $15,226,000 | 1.48% |
| NEA Management Company, LLC | 24,137,931 | $31,621,000 | 0.91% |
| VR Adviser, LLC | 1,905,265 | $2,496,000 | 0.40% |
| Sio Capital Management, LLC | 716,262 | $938,000 | 0.31% |
| Ikarian Capital, LLC | 1,622,552 | $2,126,000 | 0.28% |
| FARALLON CAPITAL MANAGEMENT LLC | 8,505,403 | $11,142,000 | 0.05% |
| Marquette Asset Management, LLC | 93,246 | $122,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,864,551 | $8,993,000 | 0.02% |
| AXA S.A. | 6,955,664 | $9,111,960 | 0.01% |